Trials / Unknown
UnknownNCT00151723
Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?
Subclinical Hyperthyroidism "To Treat or Not to Treat?" A Dutch Multicenter Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Subclinical hyperthyroidism is defined as the presence of serum free thyroxine (T4) and triiodothyronine (T3) levels within the reference range and a reduced serum thyrotrophin (TSH) level. Evidence is accumulating that it has important clinical effects. The SUBstudy is a randomised, Dutch multicenter trial to study whether radioiodine treatment prevents the development of atrial fibrillation and prevents decreases in bone mineral density in patients with endogenous subclinical hyperthyroidism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | treatment with 131I |
Timeline
- Start date
- 2004-04-01
- First posted
- 2005-09-09
- Last updated
- 2007-07-18
Locations
5 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00151723. Inclusion in this directory is not an endorsement.